This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For WednesdayBenzinga • 11/04/26
Can Q3 Earnings Get Back On Track After Being Rattled By Big Tech's AI Prints?Seeking Alpha • 11/03/26
Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR TranscriptSeeking Alpha • 11/03/26
CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL SystemBusiness Wire • 11/02/26
Progress Trial Demonstrates Edwards TAVR Is Superior to Clinical Surveillance for Moderate AS Patients With At-Risk FeaturesBusiness Wire • 11/02/26
Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 10/30/26
Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio ThrivesSeeking Alpha • 10/29/26
FDA Approval of Edwards Lifesciences' PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve DiseaseBusiness Wire • 10/21/26
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric PatientsBusiness Wire • 10/01/26
Edwards Lifesciences Corporation (EW) Presents at Deutsche Bank 2026 Healthcare Summit TranscriptSeeking Alpha • 09/16/26
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?PRNewsWire • 09/07/26